Guardant Health (MEX:GH) Cash per Share: MXN137.58 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:GH Guardant Health Inc MEX:GH
62 GF Score
Price MXN2,784.00
GF Value MXN1,113.60
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Guardant Health Cash per Share?

Guardant Health MEX:GH 62 Cash per Share is MXN137.58 as of Jun. 2026. GuruFocus rates MEX:GH with a GF Score™ of 62/100 and a GF Value™ of MXN1,113.60 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Guardant Health's Cash per Share for the quarter that ended in Jun. 2026 was MXN137.58.

Guardant Health  (MEX:GH) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Guardant Health Cash per Share Related Terms

Guardant Health Cash per Share Historical Data

* Premium members only.

The historical data trend for Guardant Health's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardant Health Cash per Share Chart

Guardant Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 188.02 192.12 163.09 141.28 165.62

Guardant Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.17 85.12 165.62 151.21 137.58
MEX:GH
62GF Score
Guardant Health Inc MEX:GH
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardant Health Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Guardant Health's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=21635.613/131
=165.62

Guardant Health's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=18381.981/134
=137.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of MXN137.58 mean?
Guardant Health (MEX:GH) has a Cash per Share of MXN137.58 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Guardant Health and its competitors.
Is Guardant Health's Cash per Share too high?
Guardant Health's current Cash per Share is MXN137.58. Overall, Guardant Health has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Cash per Share compare to MEDP and LH?
Guardant Health's Cash per Share of MXN137.58 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Diagnostics & Research company?
A good Cash per Share depends on the Medical Diagnostics & Research industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Guardant Health and its competitors. Guardant Health's current Cash per Share is MXN137.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Based on GuruFocus' analysis, Guardant Health (MEX:GH) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,113.60, compared to a current price of MXN2,784.00 — trading 150% above its estimated fair value. The current Cash per Share is MXN137.58. Guardant Health's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Guardant Health (MEX:GH), the current Cash per Share is MXN137.58 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guardant Health (MEX:GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of MXN2,784.00 is trading 150% above its estimated GF Value™ of MXN1,113.60. GuruFocus considers Guardant Health to be Significantly Overvalued.

Key valuation signals for MEX:GH:

  • Cash per Share: MXN137.58
  • GF Value™: MXN1,113.60 vs. price of MXN2,784.00 (150% above fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the MEX:GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guardant Health Business Description

Other Exchanges GH:USA1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
62GF Score

Get the complete analysis for MEX:GH

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,784.00
Price
MXN1,113.60
GF Value